Your browser doesn't support javascript.
loading
CD49d promotes disease progression in chronic lymphocytic leukemia: new insights from CD49d bimodal expression.
Tissino, Erika; Pozzo, Federico; Benedetti, Dania; Caldana, Chiara; Bittolo, Tamara; Rossi, Francesca Maria; Bomben, Riccardo; Nanni, Paola; Chivilò, Hillarj; Cattarossi, Ilaria; Zaina, Eva; Norris, Kevin; Polesel, Jerry; Gentile, Massimo; Tripepi, Giovanni; Moia, Riccardo; Santinelli, Enrico; Innocenti, Idanna; Olivieri, Jacopo; D'Arena, Giovanni; Laurenti, Luca; Zaja, Francesco; Pozzato, Gabriele; Chiarenza, Annalisa; Di Raimondo, Francesco; Rossi, Davide; Pepper, Chris; Hartmann, Tanja Nicole; Gaidano, Gianluca; Del Poeta, Giovanni; Gattei, Valter; Zucchetto, Antonella.
Affiliation
  • Tissino E; Clinical and Experimental Onco-Hematology Unit, Centro di Riferimento Oncologico di Aviano (CRO), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Aviano, Italy.
  • Pozzo F; Clinical and Experimental Onco-Hematology Unit, Centro di Riferimento Oncologico di Aviano (CRO), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Aviano, Italy.
  • Benedetti D; Clinical and Experimental Onco-Hematology Unit, Centro di Riferimento Oncologico di Aviano (CRO), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Aviano, Italy.
  • Caldana C; Clinical and Experimental Onco-Hematology Unit, Centro di Riferimento Oncologico di Aviano (CRO), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Aviano, Italy.
  • Bittolo T; Clinical and Experimental Onco-Hematology Unit, Centro di Riferimento Oncologico di Aviano (CRO), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Aviano, Italy.
  • Rossi FM; Clinical and Experimental Onco-Hematology Unit, Centro di Riferimento Oncologico di Aviano (CRO), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Aviano, Italy.
  • Bomben R; Clinical and Experimental Onco-Hematology Unit, Centro di Riferimento Oncologico di Aviano (CRO), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Aviano, Italy.
  • Nanni P; Clinical and Experimental Onco-Hematology Unit, Centro di Riferimento Oncologico di Aviano (CRO), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Aviano, Italy.
  • Chivilò H; Clinical and Experimental Onco-Hematology Unit, Centro di Riferimento Oncologico di Aviano (CRO), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Aviano, Italy.
  • Cattarossi I; Clinical and Experimental Onco-Hematology Unit, Centro di Riferimento Oncologico di Aviano (CRO), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Aviano, Italy.
  • Zaina E; Clinical and Experimental Onco-Hematology Unit, Centro di Riferimento Oncologico di Aviano (CRO), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Aviano, Italy.
  • Norris K; Division of Cancer and Genetics, School of Medicine, Cardiff University, Heath Park, Cardiff, United Kingdom.
  • Polesel J; Unit of Cancer Epidemiology, CRO, IRCCS, Aviano, Italy.
  • Gentile M; Hematology Unit, Azienda Ospedaliera (AO) of Cosenza, Cosenza, Italy.
  • Tripepi G; Nephrology Center, National Research Institute of Biomedicine and Molecular Immunology, Reggio Calabria, Italy.
  • Moia R; Division of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy.
  • Santinelli E; Division of Hematology, University of Tor Vergata, Rome, Italy.
  • Innocenti I; Dipartimento Scienze Radiologiche Radioterapiche ed Ematologiche, Fondazione Policlinico Universitario A Gemelli, IRCCS, Rome, Italy.
  • Olivieri J; Clinica Ematologica, Centro Trapianti e Terapie Cellulari "Carlo Melzi" Dipartimento Interaziendale di Salute Mentale, AO Universitaria S. Maria Misericordia, Udine, Italy.
  • D'Arena G; Onco-Haematology Department, Centro di Riferimento Oncologico della Basilicata, IRCCS, Rionero in Vulture, Italy.
  • Laurenti L; Dipartimento Scienze Radiologiche Radioterapiche ed Ematologiche, Fondazione Policlinico Universitario A Gemelli, IRCCS, Rome, Italy.
  • Zaja F; Department of Internal Medicine and Hematology, Maggiore General Hospital, University of Trieste, Trieste, Italy.
  • Pozzato G; Department of Internal Medicine and Hematology, Maggiore General Hospital, University of Trieste, Trieste, Italy.
  • Chiarenza A; Division of Hematology, Ferrarotto Hospital, University of Catania, Catania, Italy.
  • Di Raimondo F; Division of Hematology, Ferrarotto Hospital, University of Catania, Catania, Italy.
  • Rossi D; Hematology, Institute of Oncology Research, Bellinzona, Switzerland.
  • Pepper C; Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.
  • Hartmann TN; Brighton and Sussex Medical School, University of Sussex, Brighton, United Kingdom; and.
  • Gaidano G; Department of Internal Medicine I, Medical Center and Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Del Poeta G; Division of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy.
  • Gattei V; Division of Hematology, University of Tor Vergata, Rome, Italy.
  • Zucchetto A; Clinical and Experimental Onco-Hematology Unit, Centro di Riferimento Oncologico di Aviano (CRO), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Aviano, Italy.
Blood ; 135(15): 1244-1254, 2020 04 09.
Article de En | MEDLINE | ID: mdl-32006000

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Leucémie chronique lymphocytaire à cellules B / Intégrine alpha4 Type d'étude: Diagnostic_studies / Prognostic_studies Limites: Humans Langue: En Journal: Blood Année: 2020 Type de document: Article Pays d'affiliation: Italie Pays de publication: États-Unis d'Amérique

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Leucémie chronique lymphocytaire à cellules B / Intégrine alpha4 Type d'étude: Diagnostic_studies / Prognostic_studies Limites: Humans Langue: En Journal: Blood Année: 2020 Type de document: Article Pays d'affiliation: Italie Pays de publication: États-Unis d'Amérique